Viewing Study NCT07078292


Ignite Creation Date: 2025-12-24 @ 3:33 PM
Ignite Modification Date: 2025-12-26 @ 5:55 AM
Study NCT ID: NCT07078292
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-07-22
First Post: 2025-07-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Efficacy and Safety of First-line Treatment Combined With Immunotherapy for Advanced Hepatocellular Carcinoma: a Single Center, Real-world Study
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module